Literature DB >> 27494525

The plant alkaloid chelerythrine binds to chromatin, alters H3K9Ac and modulates global gene expression.

Amrita Banerjee1, Sulagna Sanyal1, Shreyasi Dutta1, Payal Chakraborty2, Prajna Paramita Das1, Kuladip Jana3, Madavan Vasudevan2, Chandrima Das1, Dipak Dasgupta1.   

Abstract

Chelerythrine (CHL), a plant alkaloid, possesses antimicrobial, anti-inflammatory, and antitumor properties. Although CHL influences several key signal transduction pathways, its ability to interact directly with nucleoprotein complex chromatin, in eukaryotic cells has so far not been looked into. Here we have demonstrated its association with hierarchically assembled chromatin components, viz. long chromatin, chromatosome, nucleosome, chromosomal DNA, and histone H3 and the consequent effect on chromatin structure. CHL was found to repress acetylation at H3K9. It is more target-specific in terms of gene expression alteration and less cytotoxic compared to its structural analog sanguinarine.

Entities:  

Keywords:  chelerythrine; cytotoxicity; dual binder; gene expression; histone H3K9 acetylation

Mesh:

Substances:

Year:  2016        PMID: 27494525     DOI: 10.1080/07391102.2016.1188154

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  3 in total

Review 1.  Interaction of the putative anticancer alkaloid chelerythrine with nucleic acids: biophysical perspectives.

Authors:  Anirban Basu; Gopinatha Suresh Kumar
Journal:  Biophys Rev       Date:  2020-10-31

2.  Chelerythrine Chloride Inhibits Stemness of Melanoma Cancer Stem-Like Cells (CSCs) Potentially via Inducing Reactive Oxygen Species and Causing Mitochondria Dysfunction.

Authors:  Hong Li; Mei He; Pengyu Zhao; Ping Liu; Wei Chen; Xuewen Xu
Journal:  Comput Math Methods Med       Date:  2022-06-18       Impact factor: 2.809

3.  Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer.

Authors:  Jiahui Wang; Yijie Song; Ning Zhang; Ning Li; Congying Liu; Bing Wang
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.